Mortality trends in the co-occurrence of urinary tract cancer and diabetes mellitus - Report - MDSpire

Mortality trends in the co-occurrence of urinary tract cancer and diabetes mellitus

  • By

  • Chen-Zhang Ou

  • Yu-Jun Xiong

  • Xiang-Da Meng

  • Tian Lv

  • Lide Song

  • May 22, 2026

  • 0 min

Share

Trends in Mortality Associated with Concurrent Urinary Tract Cancer and Diabetes Mellitus

Overview

{'text': 'This study reveals a significant increase in mortality rates among adults with concurrent urinary tract cancers and diabetes mellitus from 1999 to 2024, based on data available until 2024.'}

Background

Urinary tract cancers and diabetes mellitus frequently coexist, complicating clinical outcomes and management. Understanding mortality trends in this population is crucial for developing effective prevention and treatment strategies. The interaction between these conditions may exacerbate health risks and impact patient care.

Data Highlights

{'format': 'Consider using bullet points for clarity.'}

Key Findings

{'text': 'Include mention of statistical significance for the observed trends.'}

Clinical Implications

{'text': 'Expand on specific integrated management strategies that could be implemented.'}

Conclusion

{'text': 'Reiterate the importance of addressing the impact of the COVID-19 pandemic on mortality trends.'}

Related Resources & Content

  1. Frontiers in Endocrinology, 2026 -- Trends in acute myocardial infarction-related mortality among adults with type 1 vs. type 2 diabetes in the United States, 1999–2020
  2. Epidemiological Insights and Surgical Trends in Upper Tract Urothelial Carcinoma in Germany: A Comprehensive Population-Based Study from 2006 to 2019
  3. Frontiers in Oncology, 2026 -- Diabetes and cancer: clinical implications for integrated metabolic–oncologic care
  4. the asco post — Urothelial Cancer Survival in the Eras Before and After Immune Checkpoint Inhibitors and Antibody-Drug Conjugates
  5. EAU Guidelines on Muscle-Invasive Bladder Cancer 2025
  6. Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
  7. Competing Risk Analysis for Diabetes Mellitus Mortality in Bladder Cancer Patients

Original Source(s)

Related Content